CRP FUNDED PATENTS
2/04/2004 Update

[Back]

PATENTS AWARDED:

The following individuals have been awarded patents as an extension of CRP funding:

Eric Stanbridge, Ph.D. and Shu-Yuan Liao, M.D.
University of California, Irvine
Project Title: Evaluation of MN/CA9 Protein Expression in ASCUS Pap Smears as a Diagnostic Biomarker of Cervical Dysplasia/Neoplasia

1) Diagnostic method using expression of MN/CA9 protein in AGUS pap smears. Awarded patent 6,379,907
2) Diagnostic method using expression of MN/CA9 protein in ASCUS pap smears. Awarded patent 6,403,327

---

PATENTS PENDING:

The following individuals has submitted a patent application or an invention disclosure as an extension of CRP funding:

1. Stavros G. Demos, Ph.D. -2 patent applications filed
Lawrence Livermore National Laboratory
Project Title: Endoscopic Subsurface Optical Imaging for Cancer Detection

2. Katherine B. Ellwood, Ph.D.
University of California, Los Angeles
Project Title: PTEN regulation of the c-myc pathway in prostate cancer

3. Anjali Jain, Ph.D.
University of California, Los Angeles
Project Title: Prostate stem cell antigen as a novel tool for gene therapy

4. Lawrence W. Jones, M.D.
Huntington Memorial Hospital
Project Title: Rhodamine-123: innovative treatment for prostate cancer

5. Jiing-Dwan Lee, Ph.D.
The Scripps Research Institute
Project Title: The role of BMK-1/ERK-5 pathway in cancer cell growth

6. Carson D. Liu, M.D.
University of California, Los Angeles
Project Title: Synthetic gut hormones in the treatment of pancreatic cancer

7. Stephen J. Pandol, M.D.
University of California, Los Angeles
Project Title: Regulation of pancreatic cancer apoptosis by polyphenols

8. Andrew A. Stolz, M.D.
University of Southern California
Project Title: Molecular epidemiology of 3-alpha-HSD in prostate cancer

9. Edward Wei, Ph.D.
University of California, Berkeley
Project Title: Melanocortin Receptor Antagonists as Adjuvant Therapy for Melanoma

10. Petra Wilder-Smith, D.D.S., Ph.D.
University of California, Irvine
Project Title: Non-invasive diagnosis of pre-malignancy and malignancy

11. Lily Wu, M.D., Ph.D.
University of California, Los Angeles
Project Title: Targeted prostate cancer gene therapy using potent herpes thymidine kinase variants delivered by adenovectors

12. Nurulain Zaveri, Ph.D.
SRI International
Project Title: Antiangiogenic agents for prostate cancer therapy

California Cancer Research Program
(916) 449-5550
E-mail crp@dhs.ca.gov